Mara Inniss

Company: Obsidian Therapeutics

Job title: Director, Regulated Gene Editing & Gene Therapy Discovery

Seminars:

Developing Gene Editing Therapies That Utilize Obsidian’s cytoDRiVE™ Platform to Provide Regulated & Tunable Expression of Proteins 2:45 pm

Modulating the activity of gene editing tools like CRISPR-Cas9 to increase the specificity and reduce off-target effects Determining the best small-molecule regulators to use with the platform and validating the system in various preclinical models Demonstrating proof of concept for the ability to modulate gene editing activities in a controlled and precise mannerRead more

day: Day 1- Translation 2